专题：Spondyloarthritis Studies and Treatments

This cluster of papers focuses on the classification, diagnosis, and treatment of spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis. It covers the development of new classification criteria, assessment of disease activity, use of biologic therapies such as tumor necrosis factor inhibitors and interleukin-17 inhibitors, and the impact of genetic factors like HLA-B27.
最新文献
Prevalence of Depression in Elderly Patients With Osteoarthritis: A Cross‐Sectional Study

article Full Text OpenAlex

Associations of genetic proxies for non-steroidal anti-inflammatory drugs with increased kidney stone risk: a Mendelian randomization study

article Full Text OpenAlex

Psoriatic arthritis in transition: cytokine signaling, immune dysregulation, and therapeutic innovation

review Full Text OpenAlex

Novel MRI-Based Synthetic CT and Low-Dose CT for the Assessment of Syndesmophytes and Osteophytes in the Spine in Patients with Axial Spondyloarthritis, Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls

article Full Text OpenAlex

Corilagin regulates antigen processing and presentation by directly binding to inhibit ERAP1

article Full Text OpenAlex

Concept of dual immune inhibitors for the treatment of drug-resistant psoriatic disease

review Full Text OpenAlex

Impact of lifestyle factors and dietary patterns on serum uric acid levels and disease activity in gout: a systematic review

review Full Text OpenAlex

Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis

article Full Text OpenAlex

Letter to the editor: “Is rheumatoid arthritis associated with worse outcomes following adult spinal deformity surgery?”

letter Full Text OpenAlex

Ankylosing Spondylitis

book-chapter Full Text OpenAlex

近5年高被引文献
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

article Full Text OpenAlex 621 FWCI145.543

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

review Full Text OpenAlex 422 FWCI24.663

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

article Full Text OpenAlex 283 FWCI65.577

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

review Full Text OpenAlex 260 FWCI10.02

Axial spondyloarthritis

review Full Text OpenAlex 254 FWCI9.388

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis

article Full Text OpenAlex 238 FWCI42.086

Psoriatic arthritis

review Full Text OpenAlex 234 FWCI8.539

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study

article Full Text OpenAlex 207 FWCI37.48

Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases

review Full Text OpenAlex 192 FWCI4.479

2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases

review Full Text OpenAlex 169 FWCI9.877